Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Operating Expenses: 2021-2025

Historic Operating Expenses for P3 Health Partners (PIII) over the last 5 years, with Q3 2025 value amounting to $389.5 million.

  • P3 Health Partners' Operating Expenses fell 1697.63% to $389.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 134.38%. This contributed to the annual value of $1.8 billion for FY2024, which is 2696.83% up from last year.
  • According to the latest figures from Q3 2025, P3 Health Partners' Operating Expenses is $389.5 million, which was down 1697.63% from $389.9 million recorded in Q2 2025.
  • P3 Health Partners' 5-year Operating Expenses high stood at $1.2 billion for Q2 2022, and its period low was $164.3 million during Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $389.5 million (2025), whereas its average is $408.6 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 59281.09% in 2022, then tumbled by 7037.01% in 2023.
  • Over the past 5 years, P3 Health Partners' Operating Expenses (Quarter) stood at $188.5 million in 2021, then soared by 321.61% to $794.8 million in 2022, then plummeted by 48.27% to $411.1 million in 2023, then increased by 23.85% to $509.2 million in 2024, then decreased by 23.51% to $389.5 million in 2025.
  • Its last three reported values are $389.5 million in Q3 2025, $389.9 million for Q2 2025, and $411.3 million during Q1 2025.